We may need to adjust your dosage to help minimize any potential side effects
This is one reason I counsel patients to think about GLP-1 medications as part of a broader strategy rather than a standalone solution
no published inhibition or induction data Primary clinical concern / increased bleeding risk from additive vascular and hemostatic effects Severity estimate / moderate (theoretical), based on pharmacodynamic reasoning Monitoring needed / CBC with platelets, PT/INR, anti-Factor Xa levels, signs of bleeding Dose adjustment / no validated protocol exists
While there's no denying the effectiveness of these drugs, there are still some major concerns
Targeted screening may catch pancreatic cancer early enough to improve survival by Doug Brunk New-onset diabetes, genetic risk, and imaging advances may improve early detection and survival for patients at high risk
She told me to start at a low dose and titrate up slowly